Armata Pharmaceuticals, Inc. — Director's Dealing 2007

Jul 12, 2007

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TARGETED GENETICS CORP /WA/ (TGEN)
CIK: 0000921114
Period of Report: 2007-06-27

Reporting Person: MARXE AUSTIN W & GREENHOUSE DAVID M (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2624097	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants	$5.41	2012-01-11	Common Stock (315000)		Indirect
Warrants	$3.25	2012-06-27	Common Stock (2624097)		Indirect

Footnotes

F1: This is a joint filing by Austin W. Marxe (Marxe) and David M. Greenhouse (Greenhouse). They share voting and investment control over all securities owned by Special Situations Fund III QP, L.P (SSFQP) and Special Situations Life Sciences Fund, L.P. (LS), respectively. 1,970,052 shares of Common Stock are owned by SSFQP and 654,045 shares of Common Stock are owned by LS. The interest of Marxe and Greenhouse in the shares of Common Stock owned by SSFQP and LS is limited to the extent of his pecuniary interest.

F2: This is a joint filing by Austin W. Marxe (Marxe) and David M. Greenhouse (Greenhouse). They share voting and investment control over all securities owned by Special Situations Fund III QP, L.P (SSFQP), Special Situations Life Sciences Fund, L.P. (LS), respectively. 2,153,802 Warrants are owned by SSFQP and 785,295 Warrants are owned by LS. The interest of Marxe and Greenhouse in the shares of Warrants owned by SSFQP and LS is limited to the extent of his pecuniary interest.